Shandong Buchang Pharmaceuticals Co Ltd Financial Flexibility Index
Shandong Buchang Pharmaceuticals Co Ltd financial flexibility index. Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of CN¥-122.54 Million (operating CF CN¥-145.26 Million minus capex CN¥22.72 Million) represents 0% of total liabilities (CN¥9.50 Billion). See Shandong Buchang Pharmaceuticals Co Ltd (603858) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Financial flexibility index of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. Historical Financial Flexibility Index trend for Shandong Buchang Pharmaceuticals Co Ltd across 14 annual periods. Check Shandong Buchang Pharmaceuticals Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shandong Buchang Pharmaceuticals Co Ltd Financial Flexibility Index by Year (2011–2024)
Shandong Buchang Pharmaceuticals Co Ltd financial flexibility index by year from 2011 to 2024. Year-by-year free cash flow to debt coverage for Shandong Buchang Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Shandong Buchang Pharmaceuticals Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | CN¥1.14 Billion | CN¥939.95 Million | CN¥9.52 Billion | ▲ +210.8% |
| 2023 | 0.04x | CN¥365.66 Million | CN¥-164.26 Million | CN¥9.52 Billion | ▼ -88.7% |
| 2022 | 0.34x | CN¥3.30 Billion | CN¥2.76 Billion | CN¥9.68 Billion | ▲ +85.3% |
| 2021 | 0.18x | CN¥1.75 Billion | CN¥1.32 Billion | CN¥9.54 Billion | ▼ -33.1% |
| 2020 | 0.27x | CN¥2.50 Billion | CN¥1.96 Billion | CN¥9.08 Billion | ▼ -38.1% |
| 2019 | 0.44x | CN¥3.28 Billion | CN¥2.62 Billion | CN¥7.40 Billion | ▼ -18.6% |
| 2018 | 0.55x | CN¥3.36 Billion | CN¥2.05 Billion | CN¥6.17 Billion | ▼ -4.6% |
| 2017 | 0.57x | CN¥3.42 Billion | CN¥1.96 Billion | CN¥5.98 Billion | ▲ +45.2% |
| 2016 | 0.39x | CN¥2.35 Billion | CN¥1.67 Billion | CN¥5.96 Billion | ▲ +28.7% |
| 2015 | 0.31x | CN¥2.60 Billion | CN¥2.12 Billion | CN¥8.50 Billion | ▼ -28.3% |
| 2014 | 0.43x | CN¥1.99 Billion | CN¥1.78 Billion | CN¥4.65 Billion | ▼ -30.3% |
| 2013 | 0.61x | CN¥1.62 Billion | CN¥1.11 Billion | CN¥2.66 Billion | ▼ -46.8% |
| 2012 | 1.15x | CN¥1.89 Billion | CN¥1.35 Billion | CN¥1.65 Billion | ▼ -2.3% |
| 2011 | 1.18x | CN¥1.93 Billion | CN¥1.55 Billion | CN¥1.64 Billion | — |